Page 200 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice

190 ELECTROLYTE DISORDERS

456. Polzin DJ, Ross S, Osborne CA. Calcitriol. In: 476. Rohrer CR, Phillips LA, Ford SL, et al. Hypercalcemia in a
Bonagura J, Twedt DC, editors. Kirks current veterinary dog: a challenging case. J Am Anim Hosp Assoc
therapy XIV. St. Louis: WB Saunders; 2009. p. 892–895. 2000;36:20–5.
457. Powell GJ, Southby J, Danks JA, et al. Localization of 477. Rosenberg MP, Matus RE, Patnaik AK. Prognostic factors
parathyroid hormone-related protein in breast cancer in dogs with lymphoma and associated hypercalcemia.
metastases: increased incidence in bone compared with J Vet Intern Med 1991;5:268–71.
other sites. Cancer Res 1991;51:3059–61. 478. Rosol TJ, Capen CC. Calcium-regulating hormones and
458. Pressler BM, Rotstein DS, Law JM, et al. Hypercalcemia diseases of abnormal mineral (calcium, phosphorus, mag-
and high parathyroid hormone-related protein concentra- nesium) metabolism. In: Kaneko JJ, Harvey JW,
tion associated with malignant melanoma in a dog. J Am Bruss ML, editors. Clinical biochemistry of domestic
Vet Med Assoc 2002;221:263–5. animals. San Diego: Academic Press; 1997. p. 619–702.
459. Procino G, Carmosino M, Tamma G, et al. Extracellular 479. Rosol TJ, Capen CC. Cancer-associated hypercalcemia.
calcium antagonizes forskolin-induced aquaporin 2 traf- In: Feldman BF, Zinkl JG, Jain NC, editors. Schalm’s vet-
ficking in collecting duct cells. Kidney Int erinary hematology. Philadelphia: Lippincott Williams &
2004;66:2245–55. Wilkins; 2000. p. 660–666.
460. Ramirez JA, Goodman WG, Belin TR, et al. Calcitriol 480. Rosol TJ, Capen CC. Mechanisms of cancer-induced
therapy and calcium-regulated PTH secretion in patients hypercalcemia. Lab Invest 1992;67:680–702.
with secondary hyperparathyroidism. Am J Physiol 481. Rosol TJ, Capen CC. Pathogenesis of humoral hypercal-
1994;267:E961–67. cemia of malignancy. Domest Anim Endocrinol
461. Ramsey IK, Tebb A, Harris E, Evans H, Herrtage ME. 1988;5:1–21.
Hyperparathyroidism in dogs with hyperadrenocorticism. 482. Rosol TJ, Capen CC. Pathophysiology of calcium, pho-
J Small Anim Pract 2005;46(11):531–6. sphorus, and magnesium metabolism in animals. Vet Clin
462. Rasmussen H, Barrett P, Smallwood J, et al. Calcium ion North Am Small Anim Pract 1996;26:1155–84.
as intracellular messenger and cellular toxin. Environ 483. Rosol TJ, Capen CC. The effect of low calcium diet,
Health Perspect 1990;84:17–25. mithramycin, and dichlorodimethylene bisphosphonate
463. Rasmussen H. The cycling of calcium as an intracellular on humoral hypercalcemia of malignancy in nude mice
messenger. Sci Am 1989;261:66–73. transplanted with the canine adenocarcinoma tumor line
464. Rasor L, Pollard R, Feldman EC. Retrospective evaluation (CAC-8). J Bone Miner Res 1987;2:395–405.
of three treatment methods for primary hyperparathyroid- 484. Rosol TJ, Capen CC. Tumors of the parathyroid gland
ism in dogs. J Am Anim Hosp Assoc 2007;43(2):70–7. and circulating parathyroid hormone-related protein
465. Reber PM, Heath 3rd H. Hypocalcemic emergencies. associated with persistent hypercalcemia. Toxicol Pathol
Med Clin North Am 1995;79:93–106. 1989;17:346–56.
466. Refsal KR, Provencher-Bolliger AL, Graham PA, et al. 485. Rosol TJ, Chew DJ, Capen CC, et al. Acute hypocalcemia
Update on the diagnosis and treatment of disorders of cal- associated with infarction of parathyroid gland adenomas
cium regulation. Vet Clin North Am Small Anim Pract in two dogs. J Am Vet Med Assoc 1988;192:212–4.
2001;31:1043–62. 486. Rosol TJ, Chew DJ, Couto CG, et al. Effects of
467. Reichel H, Koeffler HP, Norman AW. The role of the vita- mithramycin on calcium metabolism and bone in dogs.
min D endocrine system in health and disease. N Engl J Vet Pathol 1992;29:223–9.
Med 1989;320:980–91. 487. Rosol TJ, Chew DJ, Hammer AS, et al. Effect of
468. Renoe BW, McDonald JM, Ladenson JH. Influence of mithramycin on hypercalcemia in dogs. J Am Anim Hosp
posture on free calcium and related variables. Clin Chem Assoc 1994;30:244–50.
1979;25:1766–9. 488. Rosol TJ, McCauley LK, Steinmeyer CL, et al. Nucleotide
469. Reusch C. Ultrasonography of the parathyroid glands in sequence of canine preproparathyroid hormone. In:
dogs-a review. Schweiz Arch Tierheilkd 2001;143:55–62. Dacke C, Danks J, Caple I, et al., The comparative endo-
470. Riccardi D. The role of extracellular calcium in the crinology of calcium regulation. Bristol, UK: Journal of
regulation of intracellular calcium and cell function (II). Endocrinology Ltd; 1996. p. 201–3.
Some answers and more questions. Cell Calcium 489. Rosol TJ, Nagode LA, Couto CG, et al. Parathyroid
2004;35:179–81. hormone (PTH)-related protein, PTH, and 1,25-
471. Richard V, Lairmore MD, Green PL, et al. Humoral dihydroxyvitamin D in dogs with cancer-associated
hypercalcemia of malignancy: severe combined immuno- hypercalcemia. Endocrinology 1992;131:1157–64.
deficient/beige mouse model of adult T-cell lymphoma 490. Rosol TJ, Nagode LA, Robertson JT, et al. Humoral hyper-
independent of human T-cell lymphotropic virus type-1 calcemia of malignancy associated with ameloblastoma in a
tax expression. Am J Pathol 2001;158:2219–28. horse. J Am Vet Med Assoc 1994;204:1930–3.
472. Rickels MR, Mandel SJ. Hypocalciuric hypercalcemia and 491. Rosol TJ, Chew DJ, Nagode LA, et al. Pathophysiology of
autoantibodies against the calcium-sensing receptor. N calcium metabolism. Vet Clin Pathol 1995;24:49–63.
Engl J Med 2004;351:2237–8 author reply 2237–2238. 492. Rosol TJ, Steinmeyer CL, McCauley LK, et al. Sequences of
473. Rijnberk A, Elsinghorst TA, Koeman JP, et al. the cDNAs encoding canine parathyroid hormone-related
Pseudohyperparathyroidism associated with perirectal protein and parathyroid hormone. Gene 1995;160:241–3.
adenocarcinomas in elderly female dogs. Tijdschr 493. Rosol TJ, Tannehill-Gregg SH, Corn S, et al. Animal
Diergeneeskd 1978;103:1069–75. models of bone metastasis. Cancer Treat Res
474. Rodan GA, Balena R. Bisphosphonates in the treatment of 2004;118:47–81.
metabolic bone diseases. Ann Med 1993;25:373–8. 494. Rosol TJ, Tannehill-Gregg SH, LeRoy BE, et al. Animal
475. Roemer-Becuwe C, Vigano A, Romano F, et al. Safety of models of bone metastasis. Cancer 2003;97
subcutaneous clodronate and efficacy in hypercalcemia of (Suppl.):748–57.
malignancy: a novel route of administration. J Pain 495. Rosol TJ. Pathogenesis of bone metastases: role of tumor-
Symptom Manage 2003;26:843–8. related proteins. J Bone Miner Res 2000;15:844–50.